The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 344:1468-1470 May 10, 2001 Number 19
NextNext

Strategies for Cardioversion of Atrial Fibrillation — Time for a Change?

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Klein, A. L.
-PubMed Citation
Dating back to the 17th-century observation that cinchona bark could correct an irregular heartbeat in patients with malaria,1 cardioversion of atrial fibrillation is one of the oldest therapies in cardiovascular medicine. In 1962, Lown et al. reported the efficacy of direct-current cardioversion of atrial fibrillation to sinus rhythm,2 thereby profoundly changing the treatment of this most common sustained arrhythmia. Restoration of sinus rhythm provided numerous physiological benefits,3 but as with most new therapies, direct-current cardioversion also had adverse outcomes, including catastrophic thromboembolism in up to 6.3 percent of patients who were not receiving anticoagulant therapy.4,5 Nonrandomized studies suggested that warfarin . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.